Committee on Safety of Medicines

Last updated

The Committee on Safety of Medicines (CSM) was an independent advisory committee that advised the UK Licensing Authority on the quality, efficacy, and safety of medicines.

Contents

Following the thalidomide tragedy of 1957 to 1961, in 1963 the government asked Sir Derrick Dunlop to set up a committee to investigate the control and introduction of new medicines in the United Kingdom. In June 1963 the Committee on Safety of Drugs (CSD) was established. [1] [2] As a result of the subsequent report to the Department of Health, which reinforced the need for specially trained doctors (clinical pharmacologists) in pharmaceutical companies and academic departments of medicine, Dunlop became the first chairman of the Committee. Under the Medicines Act 1968, the CSD was replaced in 1970 by the Medicines Commission, which established the Committee on Safety of Medicines (CSM) as a Government advisory committee under Section 4 of the Act. [3]

It was replaced on 30 October 2005 by the Commission on Human Medicines which combines the functions of both the Committee on Safety of Medicines and the Medicines Commission.

Chairs

For later chairs, see Commission on Human Medicines

See also

Related Research Articles

Povl Riis (1925-2017) was a Danish gastroenterologist.

The Commission on Human Medicines (CHM) is a committee of the UK's Medicines and Healthcare products Regulatory Agency. It was formed in October 2005, and assumed the responsibilities of the Medicines Commission and the Committee on Safety of Medicines. Membership in this various and extensive body is listed on a governmental website.

Sir Peter Stanley Harper was a British physician and academic who was University Research Professor (Emeritus) in Human Genetics at Cardiff University. His work focused on researching neurogenetics and has resulted in discoveries concerning muscular dystrophies and Huntington's disease. He was knighted in 2004 for services to medicine.

Martin Bobrow is a British geneticist, and Emeritus Fellow, Wolfson College, Cambridge.

Roderick John Flower, also known as Rod, is a British pharmacologist, and professor at Barts and The London School of Medicine and Dentistry. Dr. Flower is a member of the board of directors of Antibe Therapeutics and on the scientific advisory board of Morria.

<span class="mw-page-title-main">Tilli Tansey</span>

Elizabeth Matilda Tansey is an Emerita Professor of the history of medicine and former neurochemist, best known for her role in the Wellcome Trust's witness seminars. She previously worked at Queen Mary University of London (QMUL).

Anthony Seaton qualified in medicine from Cambridge University in 1962, and after training in Liverpool was appointed assistant professor of medicine at the University of West Virginia, USA in 1969. He became consulting chest physician at the University of Wales in 1971, and was named director of the Institute of Occupational Medicine at Edinburgh in 1978. Seaton became the head of the Department of Environmental and Occupational Medicine at the University of Aberdeen in 1988 and on retiring in 2003 became emeritus professor. He continues to write and teach and has active research interests in the causes of asthma and occupational illness.

The History of Modern Biomedicine Research Group (HoMBRG) is an academic organisation specialising in recording and publishing the oral history of twentieth and twenty-first century biomedicine. It was established in 1990 as the Wellcome Trust's History of Twentieth Century Medicine Group, and reconstituted in October 2010 as part of the School of History at Queen Mary University of London.

Professor Miles Weatherall (1920-2007) was a British pharmacologist.

<span class="mw-page-title-main">Howard Morris (biochemist)</span> British biochemist

Howard Redfern Morris FRS is a British biochemist.

Leslie Lars Iversen, was a British pharmacologist, known for his work on the neurochemistry of neurotransmission.

John Richard Batchelor FRCPath, FRCP, known as Richard, was a British immunologist, specialising in transplant immunology.

Sir Adolf William Asscher was a Dutch-born British consultant nephrologist.

<span class="mw-page-title-main">Alastair Campbell (bioethicist)</span> British theologian and bioethicist

Professor Alastair Vincent Campbell MA, BD, Th.D., FRSE is a British theologian and bioethicist. He was the founding editor of the Journal of Medical Ethics and received the Henry K. Beecher award from the Hastings Centre in 1999.

Sir Marcus Henry Richmond,, known as Mark Richmond, is a British biochemist, microbiologist and academic.

Professor Hubert Frank Woods (1937-2016), known as Frank, was a British pharmacologist.

Jeffrey Kenneth Aronson is a British clinical pharmacologist.

Sir Alasdair Muir Breckenridge, was a Scottish pharmacologist.

Professor Donald Macleod FRCSEd, FFAEM (Hon), FFSEM (Hon), FISM was a Scottish former rugby union player and a former President of the Scottish Rugby Union. A retired surgeon, he was the Scotland national rugby union team doctor for many years.

Sir Graham Allan Hart is a British retired civil servant.

References

  1. Tansey, E. M/Yabsley, The Committee On The Safety Of Drugs, A Personal Account, History of Modern Biomedicine Research Group, retrieved 2022-07-25
  2. Tansey, E; Reynolds, L. "'The Committee on Safety of Drugs'". Wellcome Collection. Retrieved 2022-07-25.
  3. "History and Aims of the Faculty of Pharmaceutical Medicine". Royal College of Physicians. Archived from the original on 2010-09-20. Retrieved 2010-05-20.
  4. 1 2 Lesser, Frank (4 December 1980). "How we keep unsafe drugs off the market". New Scientist: 634. Retrieved 10 December 2017.
  5. Daphne Christie; Tilli Tansey; Lois Reynolds, eds. (1998), Making the Human Body Transparent: The Impact of NMR and MRI; Research in General Practice; Drugs in Psychiatric Practice; The MRC Common Cold Unit, Wellcome Witnesses to Contemporary Medicine, History of Modern Biomedicine Research Group, Wikidata   Q29581621